Cetera Advisor Networks LLC Tyme Technologies, Inc. Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.6 - $1.04 $360 - $624
-600 Reduced 3.49%
16,600 $10,000
Q2 2021

Aug 13, 2021
BUY
$1.14 - $1.87 $19,608 - $32,164
17,200 New
17,200 $22,000
Q3 2020

Nov 13, 2020
SELL
$0.93 - $1.35 $8,277 - $12,015
-8,900 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$0.97 - $1.7 $8,633 - $15,130
8,900 New
8,900 $12,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email